Myopia usually worsens during childhood. High myopia is associated with retinal detachments and other serious eye conditions causing poor vision. In this study, eye drops of two concentrations of dilute atropine or placebo will be administered daily to children with myopia, ages 3-14 years, over a 4 year period. It is hoped that the dilute atropine drops will slow the worsening of myopia compared to other treatments. The purpose of this study is to determine and compare these drugs' efficacy in reducing the progression of myopia.
This study aims to create a database of people and families with hereditary retinal dystrophy in South Carolina. Patients with hereditary retinal dystrophy will be offered genetic analysis and counseling with the MUSC Center for Genomic Medicine and may donate cell samples for basic science research at the Department of Ophthalmology. This study will add to the research knowledge base of disease phenotype and epidemiology, and allow expansion of research to determine mechanism and potential therapy for inherited retinal disease